Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-AT-20-002

Center of Excellence for Natural Product Drug Interaction Research (U54, Clinical Trial Required)

Closed on November 24, 2019.

Posted
July 23, 2019
Close date
November 24, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,250,000 in first-year total cost, median $2,250,000.

Most frequent study sections

  1. Special Emphasis Panel[ZAT1 AJT (15)]1

Most frequent institutions

  1. WASHINGTON STATE UNIVERSITY1
Competing awards under RFA-AT-20-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Natural Product-Drug Interaction Research: The Roadmap to Best Practices2U54AT008909-06PAINE, MARY FWASHINGTON STATE UNIVERSITY, WA$2,250,000ZAT1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works